Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 30, 2006

View Archived Issues

Yttrium-90 microspheres allow downstaging of unresectable hepatocellular carcinoma

Genetic polymorphisms linked to atazanavir toxicity

Libivirumab/exbivirumab suppresses HBV breakthrough in liver transplant patients

TC-2429: potential application in conditions associated with alpha6 nAChR deficits

ACIP recommends Zostavax vaccination to prevent shingles in adults over 60 years

Probuphine begins phase III trial for treatment of opioid dependence

NXY-059 shows no efficacy in acute ischemic stroke

Diabetes drug KB-3305 cleared to begin clinical testing

Forbes Medi-Tech to acquire TheraPei Pharmaceuticals

AdVac-based tuberculosis vaccine begins phase I trial

European orphan drug designation for Mologen's gene therapy for renal cancer

Mundipharma acquires E.U. rights to bendamustine

Locomogene begins research collaboration on obesity drug with Kyushu University

Adenosine Therapeutics awarded grants for work in asthma, sepsis and arthritis

Ono licenses rights to RC-1291 in Japan, Korea and Taiwan

Phase III program for LymphoStat-B in SLE receives SPA

Update and preliminary results from PXD-101 program

Oral lacosamide reduces seizure frequency in epilepsy

Medivir rounds up recent developments

Several large trials presented at International Society of Hypertension Meeting: Part II

Priority review for Humira in moderate to severely active Crohn's disease

ViroMed files IND for U.S. study of genetic drug for ischemic leg disease

Velcade approved in Japan for multiple myeloma

GenOdyssee's novel natural interferon variant GEA-007.1 shows improved activity against HCV

MedImmune's novel influenza A H5N1 virus vaccine shows positive results in mice and ferrets

Preclinical profile of Wyeth's 5-HT2C agonist SCA-136 updated

Free radical scavenger Iacvita provides benefit in an animal model of stroke

New agents for obesity and other metabolic disorders imparted in recent patents

Novel tyrosinase inhibitors for skin hyperpigmentation claimed by Galderma

Recent PhotoBioChem patent describes new porphyrin derivatives for AMD

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...